What did @kmartfit actually say?
The claim is straightforward: testicular atrophy on TRT is a sign you have the wrong doctor, not an expected side effect. The creator says he has been on TRT for four years with zero shrinkage because his doctor prescribes enclomiphene, which "keeps my natural production working." He closes by directing viewers to his clinic in the comments, which is worth noting upfront as a conflict of interest.
This is a confidence-heavy claim aimed at a large audience. Some of it is grounded in real pharmacology. Some of it oversimplifies things in ways that could mislead people into chasing a protocol they may not actually need.
Does the science back this up?
Partially, yes. Testicular atrophy on exogenous testosterone is well-documented and mechanistically predictable. Exogenous testosterone suppresses the hypothalamic-pituitary axis, which reduces luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Without LH signaling, Leydig cells in the testes stop producing intratesticular testosterone, and testicular volume drops. Nieschlag et al. (2004, European Journal of Endocrinology) documented this suppression pattern extensively in hypogonadal men on testosterone therapy.
Enclomiphene, the trans-isomer of clomiphene, works as a selective estrogen receptor modulator (SERM) that blocks negative feedback at the hypothalamus and pituitary, thereby stimulating LH and FSH secretion. In theory, this can preserve intratesticular testosterone and testicular volume. Wiehle et al. (2014, Andrology) showed enclomiphene raised LH, FSH, and testosterone while maintaining sperm parameters. So the mechanism the creator describes is real. The problem is the way he frames it.
What did they get wrong, and what did they get right?
He got the mechanism roughly right. Enclomiphene can preserve testicular function during TRT, and fertility-conscious protocols often include agents like hCG or SERMs for this reason. That is not fringe medicine.
What he got wrong is the framing that atrophy means your doctor is incompetent. Testicular shrinkage on TRT without adjunct therapy is a predictable physiological response, not a clinical error. For men who are not concerned about fertility or testicular volume, many physicians and clinical guidelines do not routinely add enclomiphene or hCG. The Endocrine Society's 2018 clinical practice guidelines on male hypogonadism do not list hCG or SERMs as mandatory co-prescriptions for all patients on TRT.
Calling out "the wrong doctor" without that context could push people away from legitimate, appropriate care. There is also the referral pitch at the end. Directing 269,000 viewers to a specific clinic in exchange for comments is a marketing move dressed as medical advice. That deserves skepticism.
What should you actually know?
Testicular atrophy on TRT is common and, for many patients, clinically inconsequential. If fertility preservation matters to you, or if testicular volume is a personal concern, that is a legitimate conversation to have with your prescribing physician. Human chorionic gonadotropin (hCG) has been the more studied option for preserving intratesticular testosterone during TRT. Coviello et al. (2005, Journal of Clinical Endocrinology and Metabolism) found that adding low-dose hCG to testosterone therapy maintained intratesticular testosterone concentrations.
Enclomiphene is a real compound with real data behind it, but it is not FDA-approved specifically for use alongside TRT, and evidence for long-term co-administration with exogenous testosterone is thinner than the creator implies. Adding any adjunct therapy carries its own risk-benefit profile that should be individualized, not crowd-sourced from a TikTok comment section.
- Ask your doctor specifically about your fertility goals before starting TRT.
- If atrophy bothers you, hCG and enclomiphene are both options worth discussing, not demands you make because a social media post told you to switch clinics.
- Anyone directing you to their personal clinic from a viral video has a financial interest in your decision. Factor that in.